Author: Healio ophthalmology

Home monitoring enables early detection of CNV in AMD patients

WAILEA, Hawaii – A home monitoring device increased the chances of identifying choroidal neovascularization early and preserving vision in patients with age-related macular degeneration, according to a study presented here.Neil M. Bressler, MD, discussed results of the AREDS2 Home Study at Retina 2015. Bressler substituted for Susan B. Bressler, MD, who was unable to attend.

ICG angiography clinically useful as ancillary test

WAILEA, Hawaii – Indocyanine green angiography as an ancillary retina test is relevant in 2015 as a limited part of multimodal imaging, a presenter said.“What we’ve learned from OCT is that our clinical impression is sometimes wrong, and having ancillary tests like angiography or OCT or fundus autofluorescence can confirm what we believe to be true is very helpful. They can rule out mimicking conditions and also give us a list of therapeutic options we can offer the patient,”Jay S. Duker, MD,said at Retina 2015. “What we’re really talking about (Read more...)

Genetic testing may be helpful in diagnosing glaucoma

WAILEA, Hawaii — Genetic testing can be useful in detecting glaucoma depending on the age of the patient at diagnosis, a speaker said here.“Why is family history important? Believe it or not, about 50% of glaucoma cases have family members with glaucoma. Patients with primary affected family members are more likely to have severe disease, to become blind and to benefit from gene testing for mutations in glaucoma genes,” Janey L. Wiggs, MD, PhD, said at the Hawaiian Eye 2015 meeting.

Vision gains, retinopathy level sustained in RIDE/RISE extension study

WAILEA, Hawaii – Vision gains achieved at the conclusion of the RIDE/RISE studies were maintained in patients with diabetic macular edema who were enrolled in a 2-year open-label extension study, Michael S. Ip, MD, told colleagues at Retina 2015. Improvements in retinopathy level were also sustained.After 3 years in RIDE/RISE, 500 participants entered an open-label extension in which Lucentis 0.5 mg (ranibizumab, Genentech) was given as needed in all three treatment arms according to re-treatment criteria. Mean follow-up time was 14.1 months, less than the anticipated 24 months due to (Read more...)

OCT, visual field measurements useful for tracking glaucoma progression

WAILEA, Hawaii – Measuring visual field by optical coherence tomography can be useful in tracking glaucoma progression, according to a speaker here.“We now know that we can detect glaucoma earlier than we ever could before. What we are detecting structurally by OCT is really glaucoma,” Joel S. Schuman, MD, FACS, said at the Hawaiian Eye 2015 meeting.

Controlled blood pressure, A1c modify diabetic retinopathy progression

WAILEA, Hawaii – Retina specialists can help shape patient behavior that can modify the progression of diabetic retinopathy, a speaker said at Retina 2015.“As retina specialists, we have a responsibility to change behavior, not only because [diabetic retinopathy] is the number one cause of blindness in working age adults, but more importantly because diabetic patients fear blindness,” Allen S. Ho, MD, said.Consequently, retina specialists have more opportunity to influence their patients’ behavior because they see diabetic patients more often than they see their primary care doctor.Controlling hemoglobin A1c levels and (Read more...)

Superiority of femtosecond vs. manual methods not yet proven

WAILEA, Hawaii – Cataract surgeons should carefully weigh the pluses and minuses of traditional and femtosecond laser-assisted cataract surgery techniques, and adjust patient expectations accordingly, a speaker said here.Addressing colleagues at Hawaiian Eye 2015, Kendall E. Donaldson, MD, MS, compared traditional cataract surgery to methods performed with four femtosecond lasers: Catalys (Abbott Medical Optics), LenSx (Alcon), Victus (Bausch + Lomb) and LensAR.

Minimal VA loss, leakage associated with ‘early’ neovascular AMD

WAILEA, Hawaii – Early choroidal neovascularization should be identified when small and extrafoveal, and should be associated with minimum visual acuity loss and other characteristics not previously thought of in early detection, Neil M. Bressler, MD, told colleagues at Retina 2015.“Many people’s concept of early is what we would call late,” Bressler said. For example, visual acuity loss of 20/80 or 20/100 would be a late indicator of CNV.

Experts explore protocols for switching anti-VEGFs

WAILEA, Hawaii – There is little evidence published to help guide clinicians in making the decision to switch from one anti-VEGF therapy to another. Panelists at a round table that focused on the treatment of wet age-related macular degeneration addressed that topic at Retina 2015.“I look at the glide path to dryness,” Philip J. Rosenfeld, MD, PhD,said. “I anticipate it’s going to look better with each sequential monthly injection. You can make the argument that there are those ‘late gainers’ [of improvement], but most patients improve with those first few (Read more...)

Laser vision enhancement strategy may improve refractive outcomes

WAILEA, Hawaii — Laser vision enhancement may enhance refractive outcomes in the premium IOL patient, according to a speaker here.“There is no doubt that if we are going to continue to do these premium IOLs and we are going to try to get within 0.5 D of target, then we are going to have an enhancement strategy,” Richard L. Lindstrom, MD, said at the Hawaiian Eye 2015 meeting.